| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Allogene Therapeutics, Inc. | SVP, Finance | Common Stock | 102K | $238K | $2.34 | Jun 5, 2024 | Direct |
| Tricida, Inc. | Senior VP, Finance and CAO | Employee Stock Option (right to buy) | 14K | Aug 5, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | Jun 5, 2024 | 0 | $0 | 3 | Jun 11, 2024 | SVP, Finance |
| TCDA | Tricida, Inc. | Aug 5, 2022 | 1 | $0 | 4 | Aug 9, 2022 | Senior VP, Finance and CAO |
| TCDA | Tricida, Inc. | Feb 28, 2022 | 1 | $0 | 4 | Mar 2, 2022 | VP, Finance and CAO |
| TCDA | Tricida, Inc. | Aug 16, 2021 | 11 | $0 | 4 | Aug 18, 2021 | VP, Finance and CAO |